NEWSROOM
News & Stories
Newsroom
Press Releases
New Data Show BluePrintยฎ Identifies Estrogen Receptor Positive Breast Cancer Patients With Poor Response To Anti-Estrogen Therapy Who May Benefit From Neoadjuvant Chemotherapy
PRESS RELEASE ER+ breast cancer patients reclassified as ER+ basal-type demonstrated significant response to chemotherapy underscoring critical role of advanced diagnostic tools Results published in Nature Publishing Groupโs npj Breast Cancer IRVINE, CALIF., U.S., Read More
Agendia Announces Creation of New Center of Innovation and R&D Excellence
PRESS RELEASE Simultaneous creation of Global Lab Center of Excellence IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ 17 April 2019 โ Agendia, Inc., a world leader in precision oncology, announced today that it has created Read More
Positive Assessment Issued for Agendiaโs MammaPrintยฎ
PRESS RELEASE Determination finds that Agendiaโs MammaPrintยฎ Breast Cancer Risk of Recurrence test improves net health outcome for patients and positions the test well for further adoption by health insurance plans in the U.S. IRVINE, Read More